Home/ Stocks/ GH

Guardant Health, Inc. Common Stock

GH XNAS

$95.70 +3.74 (+4.05%) ▲ 15-min delayed

Open

$96.57

High

$98.50

Low

$89.07

Volume

3.19M

Market Cap

$12.69B

About Guardant Health, Inc. Common Stock

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Sector: SERVICES-MEDICAL LABORATORIES Employees: 2.5K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$301.67M	$-112,075,000	$-0.85
FY 2025	$982.02M	$-416,277,000	$-3.32
Q2 2025	$232.09M	$-99,899,000	$-0.80
Q1 2025	$203.47M	$-95,159,000	$-0.77

Related Market News

No specific coverage for GH yet. Check out our latest market news or earnings calendar.

Get GH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Guardant Health, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.